These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 16240062)
1. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. Machi J; Bueno RS; Wong LL World J Surg; 2005 Nov; 29(11):1364-73. PubMed ID: 16240062 [TBL] [Abstract][Full Text] [Related]
2. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J; Chen MH; Yang W; Wu W; Yan K Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144 [TBL] [Abstract][Full Text] [Related]
4. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276 [TBL] [Abstract][Full Text] [Related]
5. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H; J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896 [TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410 [TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493 [TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation for unresectable tumors of the liver. Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476 [TBL] [Abstract][Full Text] [Related]
9. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence. Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283 [TBL] [Abstract][Full Text] [Related]
11. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395 [TBL] [Abstract][Full Text] [Related]
12. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors. Sucandy I; Cheek S; Golas BJ; Tsung A; Geller DA; Marsh JW HPB (Oxford); 2016 Sep; 18(9):756-63. PubMed ID: 27593593 [TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial. Liao M; Zhong X; Zhang J; Liu Y; Zhu Z; Wu H; Zeng Y; Huang J J Surg Oncol; 2017 Jun; 115(8):971-979. PubMed ID: 28334430 [TBL] [Abstract][Full Text] [Related]
14. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies. Qiu J; Chen S; Wu H J Surg Res; 2014 May; 188(1):14-20. PubMed ID: 24387841 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma. Sakoda M; Ueno S; Iino S; Minami K; Ando K; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S World J Surg; 2013 Mar; 37(3):597-601. PubMed ID: 23192169 [TBL] [Abstract][Full Text] [Related]
18. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684 [TBL] [Abstract][Full Text] [Related]
19. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512 [TBL] [Abstract][Full Text] [Related]
20. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]